Αρχική World News Superior EFS and OS in Patients with Nonmetastatic Osteosarcoma and Unfavourable Prognosis... World News Superior EFS and OS in Patients with Nonmetastatic Osteosarcoma and Unfavourable Prognosis when Adjuvant Mifamurtide is Combined with High-Dose Ifosfamide Από Ogkologos - 28 Αυγούστου, 2025 354 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ISG/OS-2 and GEIS-33 studies Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR High-Deductible Health Plans Linked to Delayed Diagnosis and Treatment of Breast... 23 Απριλίου, 2019 Mom Fighting Breast Cancer Says Her Haunted House Is Something To... 30 Οκτωβρίου, 2019 Telehealth-Based Cancer Care Surged during COVID. Will It Continue? 9 Μαρτίου, 2022 Strict Safety Measures in Austria Results in Low SARS-CoV-2 Detection Rate... 17 Αυγούστου, 2020 Φόρτωση περισσοτέρων HOT NEWS Patient Guide in Testicular Cancer Now Available Also in French ¿Cómo están cambiando los requisitos de elegibilidad para los ensayos clínicos... Rucaparib Approved as Maintenance Treatment for Some Recurrent Ovarian Cancers The Caregiver Curve